Selected article for: "acute distress and liver disease"

Author: Lenti, Marco Vincenzo; Borrelli de Andreis, Federica; Pellegrino, Ivan; Klersy, Catherine; Merli, Stefania; Miceli, Emanuela; Aronico, Nicola; Mengoli, Caterina; Di Stefano, Michele; Cococcia, Sara; Santacroce, Giovanni; Soriano, Simone; Melazzini, Federica; Delliponti, Mariangela; Baldanti, Fausto; Triarico, Antonio; Corazza, Gino Roberto; Pinzani, Massimo; Di Sabatino, Antonio
Title: Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy
  • Cord-id: hmyibkez
  • Document date: 2020_7_10
  • ID: hmyibkez
    Snippet: Little is known regarding coronavirus disease 2019 (COVID-19) clinical spectrum in non-Asian populations. We herein describe the impact of COVID-19 on liver function in 100 COVID-19 consecutive patients (median age 70 years, range 25–97; 79 males) who were admitted to our internal medicine unit in March 2020. We retrospectively assessed liver function tests, taking into account demographic characteristics and clinical outcome. A patient was considered as having liver injury when alanine aminot
    Document: Little is known regarding coronavirus disease 2019 (COVID-19) clinical spectrum in non-Asian populations. We herein describe the impact of COVID-19 on liver function in 100 COVID-19 consecutive patients (median age 70 years, range 25–97; 79 males) who were admitted to our internal medicine unit in March 2020. We retrospectively assessed liver function tests, taking into account demographic characteristics and clinical outcome. A patient was considered as having liver injury when alanine aminotransferase (ALT) was > 50 mU/ml, gamma-glutamyl transpeptidase (GGT) > 50 mU/ml, or total bilirubin > 1.1 mg/dl. Spearman correlation coefficient for laboratory data and bivariable analysis for mortality and/or need for intensive care were assessed. A minority of patients (18.6%) were obese, and most patients were non- or moderate-drinkers (88.5%). Liver function tests were altered in 62.4% of patients, and improved during follow-up. None of the seven patients with known chronic liver disease had liver decompensation. Only one patient developed acute liver failure. In patients with altered liver function tests, PaO(2)/FiO(2) < 200 was associated with greater mortality and need for intensive care (HR 2.34, 95% CI 1.07–5.11, p = 0.033). To conclude, a high prevalence of altered liver function tests was noticed in Italian patients with COVID-19, and this was associated with worse outcomes when developing severe acute respiratory distress syndrome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11739-020-02425-w) contains supplementary material, which is available to authorized users.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and academic tertiary referral hospital: 1
    • abdominal pain and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abdominal pain and acute liver failure: 1, 2, 3, 4
    • abdominal pain and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • abdominal pain and admission time: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and liver condition: 1, 2
    • abnormal liver function and acute disease: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal liver function and acute liver failure: 1, 2, 3
    • abnormal liver function and acute respiratory distress syndrome: 1
    • abnormal liver function and admission time: 1, 2, 3
    • abnormal liver function and liver condition: 1, 2
    • abnormal liver function and liver cytopathic effect: 1
    • abnormal liver function test and acute disease: 1
    • academic tertiary referral hospital and acute disease: 1
    • academic tertiary referral hospital and acute respiratory distress syndrome: 1
    • active inflammation and acute disease: 1, 2, 3
    • active inflammation and acute respiratory distress syndrome: 1, 2, 3
    • acute disease and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and liver condition: 1, 2, 3